Cylex, Inc.
8980 Old Annapolis Road, Suite I
Columbia
Maryland
21045
United States
Tel: 410-964-0236-or-888-873-0871
Fax: 410-964-0367
Website: http://www.cylex.net/
Email: contact@cylex.net
25 articles about Cylex, Inc.
-
ViraCor-IBT Laboratories Acquires Assets of Cylex, Inc.
2/6/2013
-
Cylex, Inc. Awarded New CPT Code For Its ImmuKnow(R) Assay
1/12/2010
-
Cylex, Inc. Appoints Brad L. Stewart as CEO
9/10/2009
-
Cylex, Inc.: Three Independent Studies Include the ImmuKnow(R) Assay to Manage and Optimize Immunosuppression Therapy in Transplant Patients
6/1/2009
-
Cylex, Inc. Release: An Independent Study Reports on the Utility of ImmuKnow(R), the Cylex(TM) Immune Cell Function Assay, for Monitoring Heart Transplant Recipients
4/24/2009
-
Cylex, Inc. Receives ISO 13485:2003 and 9001:2000 Quality Certifications
10/2/2008
-
Sales Growth Spurs Cylex, Inc. to Expand Staff, Office Space
9/29/2008
-
Cylex, Inc. Patented ImmuKnow(R) Immune Cell Function Assay to be Studied in Italian Liver Transplant Patients
8/29/2008
-
Cylex, Inc. New Data Support Role for Monitoring of Cell-Mediated Immunity in Adult Patients Following Renal Transplantation
8/22/2008
-
Cylex, Inc. New Data Support Earlier Suggested Guidance for Levels of Cell-Mediated Immunity in Pediatric Liver Transplant Patients
8/22/2008
-
Cylex, Inc. Announces Significant Expansions and Reassignments of Personnel
8/22/2008
-
University of Miami Team Confirms Value of Monitoring Cell-Mediated Immunity Pre- and Post-Transplant in Management of Kidney Transplant Recipients; New Data Presented at Annual American Transplant Congress in Toronto
6/4/2008
-
Multiple Independent Studies Report on Use of Cylex, Inc.'s Immune Cell Function Assay in Postoperative Monitoring of Kidney, Liver, and Heart Transplant Recipients To Be Presented at the Annual American Transplant Congress
6/3/2008
-
Cylex, Inc. and University of Pittsburgh Medical Center Release: Cell-Mediated Immunity And Anti-HLA Antibody Tests Provide Insight To Immune Response In Renal Transplant Patients; Data Presented at American Transplant Congress
6/2/2008
-
Independent Studies Report on Possible Roles for Cylex, Inc.'s Immune Cell Function Assay in Monitoring of Heart and Lung Transplant Recipients
4/10/2008
-
Cylex, Inc. Announces Brad L. Stewart as President of the Company
4/8/2008
-
New Independent Research Study Indicates That Cylex, Inc.'s ImmuKnow Test May Identify Kidney Transplant Patients at Risk for Early Acute Rejection
2/20/2008
-
Cylex, Inc. Announces Paul R. Sohmer, MD Joins Board of Directors and Assumes Role of Acting CEO
1/24/2008
-
Cylex, Inc. Closes Third Round of Private Financing With Investment From Siemens Venture Capital GmbH
3/6/2007
-
Cylex, Inc.'s Immune Function Test, ImmuKnow(R), Identifies Optimal Immune Status For Post-Transplant Therapy
9/12/2006